CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 53543-53900 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T308","span":{"begin":0,"end":357},"obj":"Sentence"},{"id":"T41425","span":{"begin":0,"end":357},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Kumar and coworkers [120] synthesized multiple pyrazolone analogues as SARS-coronavirus (CoV) and Middle East Respiratory Syndrome (MERS)-CoV 3C-like protease inhibitors, among which compounds 167 and 168 (Fig. 16 ) exerted the strongest inhibitory effects against SARS and MERS with IC 50 values of 6.4 and 5.8 mM (167), 5.8 and 7.4 mM (168), respectively."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T70","span":{"begin":71,"end":87},"obj":"Disease"},{"id":"T71","span":{"begin":71,"end":75},"obj":"Disease"},{"id":"T72","span":{"begin":265,"end":269},"obj":"Disease"},{"id":"T69893","span":{"begin":71,"end":87},"obj":"Disease"},{"id":"T72712","span":{"begin":71,"end":75},"obj":"Disease"},{"id":"T78536","span":{"begin":265,"end":269},"obj":"Disease"}],"attributes":[{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A88607","pred":"mondo_id","subj":"T69893","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A85916","pred":"mondo_id","subj":"T72712","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A26567","pred":"mondo_id","subj":"T78536","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Kumar and coworkers [120] synthesized multiple pyrazolone analogues as SARS-coronavirus (CoV) and Middle East Respiratory Syndrome (MERS)-CoV 3C-like protease inhibitors, among which compounds 167 and 168 (Fig. 16 ) exerted the strongest inhibitory effects against SARS and MERS with IC 50 values of 6.4 and 5.8 mM (167), 5.8 and 7.4 mM (168), respectively."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T22","span":{"begin":0,"end":357},"obj":"Sentence"}],"text":"Kumar and coworkers [120] synthesized multiple pyrazolone analogues as SARS-coronavirus (CoV) and Middle East Respiratory Syndrome (MERS)-CoV 3C-like protease inhibitors, among which compounds 167 and 168 (Fig. 16 ) exerted the strongest inhibitory effects against SARS and MERS with IC 50 values of 6.4 and 5.8 mM (167), 5.8 and 7.4 mM (168), respectively."}